MAPT and Alzheimer disease: Remarkably, these seemingly innocuous exchanges have a profound impact on risk of developing sporadic, late-onset Alzheimer’s disease (AD),[5–9] (Fig 1) as well as the extent of AD-defining amyloid-β (Aβ) and hyper-phosphorylated Tau (pTau) containing lesions.[9, 10]